David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.77% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
iShares S&P 500 Value ETF
IVE
$50.3B
| $461K | ﹤0.01% |
+2,653
| New | +$426K |
|
3402
PubMatic
PUBM
$749M
| $460K | ﹤0.01% |
28,184
+5,059
| +22% | +$73.4K |
|
3403
Hawkins
HWKN
$2.46B
| $459K | ﹤0.01% |
6,519
-1,291
| -17% | -$80.3K |
|
3404
1st Source
SRCE
$2.06B
| $458K | ﹤0.01% |
8,330
-10,445
| -56% | -$501K |
|
3405
Koppers
KOP
$858M
| $457K | ﹤0.01% |
8,914
+1,953
| +28% | +$81.7K |
|
3406
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.68B
| $456K | ﹤0.01% |
+4,812
| New | +$439K |
|
3407
CALL
Arbor Realty Trust
ABR
$970M
| $455K | ﹤0.01% |
30,000
| – | – |
|
3408
PUT
LendingTree
TREE
$437M
| $455K | ﹤0.01% |
15,000
-52,700
| -78% | -$955K |
|
3409
PUT
Applied Materials
AMAT
$382B
| $454K | ﹤0.01% |
+2,800
| New | +$411K |
|
|
MRTX
3410
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $452K | ﹤0.01% |
7,693
-131,920
| -94% | -$7.42M |
|
3411
Pacer Lunt Large Cap Alternator ETF
ALTL
$91.5M
| $451K | ﹤0.01% |
+13,420
| New | +$443K |
|
3412
Malibu Boats
MBUU
$568M
| $451K | ﹤0.01% |
8,227
-24,346
| -75% | -$1.17M |
|
|
SEE
3413
DELISTED
Sealed Air
SEE
| $449K | ﹤0.01% |
12,296
-249,488
| -95% | -$8.18M |
|
|
AMK
3414
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $448K | ﹤0.01% |
14,957
+5,095
| +52% | +$131K |
|
3415
Mizuho Financial
MFG
$126B
| $447K | ﹤0.01% |
129,811
+113,147
| +679% | +$384K |
|
|
LTC
3416
LTC Properties
LTC
$2.19B
| $446K | ﹤0.01% |
13,900
+3,547
| +34% | +$115K |
|
3417
Argan
AGX
$6.44B
| $446K | ﹤0.01% |
9,527
+5,081
| +114% | +$232K |
|
3418
Rayonier
RYN
$6.28B
| $446K | ﹤0.01% |
14,706
-45,037
| -75% | -$1.2M |
|
3419
Gladstone Capital
GLAD
$445M
| $446K | ﹤0.01% |
20,823
-2,757
| -12% | -$55K |
|
3420
Revolution Medicines Inc Warrant
RVMDW
$139M
| $445K | ﹤0.01% |
+1,347,439
| New | +$602K |
|
3421
CALL
Ferguson
FERG
$45.4B
| $444K | ﹤0.01% |
2,300
| – | – |
|
3422
Beazer Homes USA
BZH
$885M
| $443K | ﹤0.01% |
13,121
-135,693
| -91% | -$3.71M |
|
3423
CALL
Brookfield Renewable
BEPC
$6.18B
| $443K | ﹤0.01% |
+15,400
| New | +$393K |
|
3424
Stem
STEM
$55.5M
| $442K | ﹤0.01% |
+5,698
| New | +$393K |
|
3425
Atour Lifestyle Holdings
ATAT
$4.83B
| $442K | ﹤0.01% |
+25,463
| New | +$460K |
|
Similar funds
David Shaw's Q4 2023 Portfolio in Review
As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
- David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- David Shaw opened 575 new positions and closed 527 in Q4 2023.
- David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.